BlackRock, Inc. 13D and 13G filings for Concert Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | Concert Pharmaceuticals, Inc. CNCE |
BlackRock Inc. BLK |
670,035 2.100% |
-1,534,474 (-69.61%) |
Filing |
| 2021-02-02 2:56 pm Purchase |
2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
BlackRock Inc. BLK |
2,204,509 7.200% |
735,550 (+50.07%) |
Filing |